GI
EXAS

GAMCO Investors’s Exact Sciences EXAS Stock Holding History

GAMCO Investors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,000
Closed -$2.23M – 1030
2025
Q4 		$2.23M Buy
+22,000
New +$1.77M 0.02% 511
2023
Q2 		– Sell
-4,500
Closed -$305K – 872
2023
Q1 		$305K Hold
4,500
– – ﹤0.01% 761
2022
Q4 		$223K Buy
+4,500
New +$184K ﹤0.01% 817

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GAMCO Investors's EXAS Position: Q1 2026 in Review

GAMCO Investors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 22,000 shares — an estimated $2.23M sold.

GAMCO Investors first reported a position in EXAS in Q4 2022 and held it in 3 quarters. The position peaked at $2.23M in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • GAMCO Investors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • GAMCO Investors sold 22,000 Exact Sciences shares in Q1 2026, an estimated $2.23M.
  • GAMCO Investors first reported a position in Exact Sciences in Q4 2022 and held it in 3 quarters.
  • GAMCO Investors's Exact Sciences position peaked at $2.23M in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on GAMCO Investors's 13F filing for Q1 2026, filed 14 May 2026.